Author:
Bonato Matteo,Semenzato Umberto,Tinè Mariaenrica,Bazzan Erica,Damin Marco,Biondini Davide,Casara Alvise,Romagnoli Micaela,Turato Graziella,Cosio Manuel G.,Saetta Marina,Baraldo Simonetta
Abstract
The impact that COVID-19 could have on patients with COPD is a real concern. In this study we evaluated, in a cohort of longitudinally followed COPD subjects, the incidence of COVID-19, seeking for possible risk factors and prognostic factors predicting the clinical outcome. In our cohort of 370 patients (followed for 5.3 ± 2.7 years), 22 developed COVID-19 (COPD/COVID-19+) between February/November 2020 (5.9%). Cardio-metabolic conditions (hypertension, dyslipidemia, obesity, diabetes) but not respiratory abnormalities (FEV1, DLCO, emphysema and exacerbation history), were risk factors for development of COVID-19 in COPD patients. Out of the 22 COPD/COVID-19+ patients, 10 needed intensive care. Low DLCO and emphysema, but also metabolic comorbidities, were related to the need for intensive care.
Reference10 articles.
1. Immune dysfunction in patients with chronic obstructive pulmonary disease;Bhat;Ann Am Thorac Soc,2015
2. COVID-19 and COPD;Leung;Eur Respir J,2020
3. Health services burden of undiagnosed and overdiagnosed COPD;Gershon;Chest,2018
4. Global Strategy for Diagnosis, Management, and Prevention of COPD2021
5. Istituto Nazionale di Statistica (ISTAT)Impatto dell'epidemia COVID-19 sulla mortalità totale della popolazione residente periodo gennaio-novembre 2020
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献